Why iTeos Therapeutics Shares Are Surging Today
iTeos Therapeutics Inc (NASDAQ: ITOS) shares are trading higher by 36.7% at $27.38 Monday afternoon after the company and GlaxoSmithKline announced an agreement to co-develop and co-commercialize EOS-448, an anti-TIGIT monoclonal antibody.